tepmetko
merck europe b.v. - tepotinib hydrochloride monohydrate - karsinooma, ei-pienisoluinen keuhko - antineoplastiset aineet - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.
valeriamed yö/natt tabletti, päällystetty
pfizer aps - valerianae root pura henki kuiva - tabletti, päällystetty - valerianae radix
venlafaxin hexal 37.5 mg depotkapseli, kova
hexal a/s - venlafaxini hydrochloridum - depotkapseli, kova - 37.5 mg - venlafaksiini
venlafaxin hexal 75 mg depotkapseli, kova
hexal a/s - venlafaxini hydrochloridum - depotkapseli, kova - 75 mg - venlafaksiini
venlafaxin hexal 150 mg depotkapseli, kova
hexal a/s - venlafaxini hydrochloridum - depotkapseli, kova - 150 mg - venlafaksiini
pregabalin stada 25 mg kapseli, kova
stada arzneimittel ag stada arzneimittel ag - pregabalinum - kapseli, kova - 25 mg - pregabaliini
pregabalin stada 75 mg kapseli, kova
stada arzneimittel ag stada arzneimittel ag - pregabalinum - kapseli, kova - 75 mg - pregabaliini
pregabalin stada 150 mg kapseli, kova
stada arzneimittel ag stada arzneimittel ag - pregabalinum - kapseli, kova - 150 mg - pregabaliini
pregabalin stada 300 mg kapseli, kova
stada arzneimittel ag stada arzneimittel ag - pregabalinum - kapseli, kova - 300 mg - pregabaliini
pregabalin ratiopharm 25 mg kapseli, kova
ratiopharm gmbh - pregabalin - kapseli, kova - 25 mg - pregabaliini